News

Rivus Batteries has closed a EUR 2 million seed round - building European energy storage resilience with organic flow...

We are creating more Space for Scientific Innovation, and with it, an ecosystem of research, entrepreneurship, and...

Transforming early-stage Tech into Companies

The company secured €4 million in total funding—including an oversubscribed €2 million pre-seed round co-led by XISTA...

Join the bigX innovation exchange conference on October 1st.

The Austrian startup's software shrinks AI models by up to 80%, letting companies run more AI on less hardware.

Successful conclusion of this year’s xbio Biotech Enterprise Masterclass xbio, led by XISTA and the University of Vienna...

A radically new biological approach for cancer patients: CollimateHealth is developing the first clinically scalable...

The Vienna-based deep-tech TU Wien spin-off will accelerate international commercialization of the world’s first...

4DMedical Limited (ASX: 4DX), a global leader in advanced respiratory imaging, just announced a major expansion into...

The new “Academic Spin-out Alliance” formed by AIT, BOKU, MedUni Vienna, ISTA, XISTA, TU Vienna,
the University of...

FUJIFILM backs VALANX Biotech, a XISTA Science Ventures portfolio company developing precision technologies for antibody...

Factory planning has historically been constrained by time, manual effort, and limited iteration. Each layout represents...

It turns out scientists are curious about entrepreneurship.

From Science to Company Building

Autonomous systems must operate in environments that are complex, dynamic, and unpredictable. Testing these systems in...

XISTA Science Ventures portfolio company Vitrealab Closes $11 Million Series A to Accelerate Development of Quantum...

Augmented reality has long been constrained by hardware — particularly the light engine, where size, efficiency, and...

Spotlight on ISTA researcher Eugenia Iofinova and her work on private and personal AI

XISTA Science Ventures and the BioInnovation Institute (BII) in Copenhagen are excited to offer a new collaboration...

Rapid diagnostics have become a cornerstone of modern healthcare — accessible, fast, and scalable. Yet their limitations...

Talent chooses Europe when Europe chooses talent.
A reminder that strong science and great places to live go hand in...

A new research collaboration between ISTA and Google strengthens the bridge between scientific discovery, technology...

XISTA science ventures continues to expand its investment platform for science-based entrepreneurship, now managing...

XISTA science ventures continues to expand its investment platform for science-based entrepreneurship, now managing...

xbio, the entrepreneurship masterclass for life scientists, has evolved into a national programme
connecting over a...

Most advanced AI models are designed for centralized infrastructure. But many applications — from vehicles to edge...

How does a scientist turn a persistent industry problem into a venture-backed solution? In this XISTA Fellowship Story...

Qui eu culpa incididunt occaecat. Culpa incididunt occaecat, mollit. Mollit ea ea cupidatat proident, duis irure nulla...

Strong life sciences investments require more than capital — they depend on deep scientific and industry expertise...

A significant portion of critical infrastructure lies underwater — yet remains difficult to inspect and monitor.

At XISTA, we are building while growing: Expanding our team, launching new ventures, forming strategic partnerships, and...

Syntropic Medical has announced the launch of a groundbreaking clinical study testing a new non-invasive brain...

ReCatalyst, a xista portfolio company pioneering next-generation nanocatalysts for the hydrogen economy, has announced...

Scientific breakthroughs are transforming industries at an unprecedented pace. Yet the key challenge remains: How do we...

XISTA Science Ventures is now part of the EIC Trusted Investors Network — joining over 100 leading investors to support...

A fireside chat with Stephan Huber and Markus Wanko

On September 19th, the tranquil Campus of the Institute for Science and Technology Austria (ISTA) transformed into a...

xbio alumna Gunpreet Oberoi and her Safe Vascular Access Needle (SVAN) win 3D Printing Life Sciences Award, on top of...

With a varied program, xista and VERBUND X showed at Venture Day how the ecosystem in the cleantech sector can be...

xista science ventures portfolio companies Syntropic and VALANX Biotech present their technologies as part of the...

xbio Biotech Enterprise Masterclass celebrates it's second run! On Demo Day cohort 2024 pitched their innovations to 60+...

Our Venture Partner, Bernhard Petermeier, was featured in Cleantech for Europe’s Voices of Innovation series commenting...

President of the European Commission Ursula von der Leyen, Finance Minister Brunner, and ISTA President Hetzer join...

xista science ventures hosted it's much-anticipated “Investors and Portfolio Day” centered around the theme “Shaping...